clinical research

nference and Vanderbilt University Medical Center sign agreement to advance real-world evidence generation in complex disease populations

nference, a science-first software company transforming healthcare by making biomedical data computable, and Vanderbilt University Medical Center have announced a strategic agreement aimed at advancing research through the deployment of nference’s state-of-the-art federated clinical analytics platform. By leveraging the power of federated AI and machine learning, this collaboration will expand clinical insights in key research areas.

Grant helps early-career researchers affected by COVID-19

Vanderbilt University Medical Center has received $550,000 from the Doris Duke Charitable Foundation’s (DDCF) COVID-19 Fund to Retain Clinical Scientists.

The “orange team,” led by Buddy Creech, MD, director of the Vanderbilt Vaccine Research Program, assembles in the old Clinical Research Center space in Medical Center North on the first day of the phase 3 Moderna vaccine study this summer.

Coronavirus ‘crusaders’ spur VUMC research achievements

The development of the vaccines, monoclonal antibodies and antiviral drugs that ultimately will defeat COVID-19 wouldn’t have been possible had it not been for the unflagging and selfless efforts of a global army of research nurses, laboratory personnel, recruiters and other staff.

Gene identified that increases risk of antibiotic reaction

Researchers at Vanderbilt University Medical Center and colleagues have identified a gene that increases the risk for a severe and potentially life-threatening reaction to the commonly prescribed antibiotic vancomycin.

Research, patient care drive Emergency Medicine’s Collins

Sean Collins, MD, MSc, was no stranger to Vanderbilt University Medical Center when he was offered a faculty position in Emergency Medicine in 2011. A heart failure study that he was leading at the University of Cincinnati included faculty and patients from Vanderbilt.

Daughter’s rare adverse drug reaction inspires family’s donation

Last year Paul and Wanpen Anderson of Champaign, Illinois, were preparing to celebrate the Christmas holidays with their two children when their 22-year-old daughter, Angela, developed a rare adverse drug reaction called SJS/TEN.

1 2